Clinical Trial

A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is designed to investigate the effect of treatment with Zovaglutide (ZT002 Injection) on the corrected cardiac QT interval relative to a placebo control in healthy participants.
Trial Details
NCT Number NCT07697846
Lead Sponsor Beijing QL Biopharmaceutical Co.,Ltd
Conditions Overweight, Obesity
Enrollment 40 participants
Start Date 2026-07-18
Primary Completion 2027-01-13 (estimated)
Study Completion 2027-03-24 (estimated)
Updated on ClinicalTrials.gov 2026-07-13